Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...

DEE Development Engineers IPO allotment finalised.(https://www.deepiping.com/) DEE Development Engineers IPO allotment date: The DEE Development Engineers IPO share ...

The company said this new commitment to its facility in Germany goes hand in hand with its recently announced ReciPredict, an initiative intended to streamline the product development cycle. Recipharm ...

Small biotechs in early development of cell therapies are often surprised by the strictness of commercial manufacturing standards. That’s the view of Luděk Sojka, PhD, CEO of contract developer and ...

Bio: Mary Kay Bates is a Senior Global Cell Culture Scientist with Thermo Fisher Scientific, where she provides cell culture expertise to colleagues and customers. Her knowledge is based on twenty ...

CRISPR-Cas9 is one of the most commonly leveraged non-viral editing tools to engineer cells for therapeutics applications. It is a nuclease-based genome editing system which has seen exponential ...

Aragen unveils CHOMax, an accelerated platform for DNA to IND-enabling clinical supply in 10 months: Our Bureau, Bengaluru Monday, January 12, 2026, 14:15 Hrs [IST] Aragen launche ...

NEWARK, Del., July 18, 2024 /PRNewswire/ -- At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Resilient ...

DEE Development Engineers IPO: The initial public offering (IPO) of specialized process piping solutions provider DEE Development Engineers Ltd has been receiving strong response from investors. Today ...